CCND2P1

Across TCGA pan-cancer cohorts, CCND2P1 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated CCND2P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher CCND2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCND2P1 expression acts as an unfavorable survival marker, although some lineages such as LIHC and ESCA show a favorable association.

OV, BLCA, and CHOL are the cancer types where CCND2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.366	0.554	<.001	108	view →
BLCA	OS	Tertile	IV	0.387	0.630	.005	57	view →
CHOL	OS	Quartile	II,III,IV	0.111	0.851	<.001	51	view →
LIHC	OS	Tertile	III,IV	0.585	0.217	.003	45	view →
HNSC	OS	Median	IV	0.136	0.381	.002	35	view →
DLBC	OS	Quartile	II,III,IV	0.257	1.000	.001	33	view →
ESCA	OS	Median	III,IV	0.674	0.416	.006	24	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
PCPG	OS	Tertile	All	0.032	0.948	<.001	18	view →
LUAD	DFS	Tertile	IV	0.370	0.702	.045	18	view →
STAD	DFS	Median	IV	0.118	0.579	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

CCND2P1–OV (DFS)

Open the OV breakdown →